Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

SELLAS Life Sciences Group, Inc.

  • Angelos Stergiou, SELLAS Life Sciences Group

SELLAS Life Sciences is a late-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications.

  • Date:Tuesday, February 12
  • Time:9:30 AM - 9:45 AM
  • Room:Hudson/Empire
  • Location:7th Floor
  • Session Type:Company Presentation
  • Please submit your session questions in advance at:http://bit.ly/BIOCEO19question
  • Submission ID:23305
  • Company Presentation - Presentation Type:Publicly Traded Company
  • Goal for Presentation:Public forum for presentation
  • Company Website:https://www.sellaslifesciences.com
  • Company HQ City:New York
  • Company HQ State:New York
  • Company HQ Country:United States
  • Ticker:SLS-USQ
  • Exchange:NASDAQ
  • Main Therapeutic Focus:Oncology
  • Lead Product in Development:Galinpepimut-S
  • Development Phase of Primary Product:Phase III
Speakers
Angelos Stergiou
SELLAS Life Sciences Group
Back